Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-07
2006-03-07
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C564S305000
Reexamination Certificate
active
07009060
ABSTRACT:
The present invention relates to a β3adrenergic receptor agonist of formula I:or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
REFERENCES:
patent: 4276304 (1981-06-01), Ikezaki et al.
patent: 4826847 (1989-05-01), Michel et al.
patent: 5808080 (1998-09-01), Bell et al.
patent: 5977154 (1999-11-01), Bell et al.
patent: 6011048 (2000-01-01), Mathvink et al.
patent: 2830884 (1979-01-01), None
patent: 166331 (1986-01-01), None
patent: 221414 (1987-05-01), None
patent: 236624 (1987-09-01), None
patent: 611003 (1994-08-01), None
patent: 678511 (1995-10-01), None
patent: 764640 (1997-03-01), None
patent: 827746 (1998-03-01), None
patent: 1549945 (1979-08-01), None
patent: WO 95/29159 (1995-11-01), None
patent: WO 97/10825 (1997-03-01), None
patent: WO 97/46556 (1997-12-01), None
patent: WO 98/4526 (1998-02-01), None
patent: WO 98/9625 (1998-03-01), None
patent: WO 98/32753 (1998-07-01), None
patent: WO 00/40560 (2000-07-01), None
patent: WO 00/44721 (2000-08-01), None
patent: WO 01/7026 (2001-02-01), None
patent: WO 01/35947 (2001-05-01), None
patent: WO 01/36412 (2001-05-01), None
patent: WO 01/53298 (2001-07-01), None
patent: WO 02/6276 (2002-01-01), None
patent: WO 02/38543 (2002-05-01), None
patent: WO 03/16276 (2003-02-01), None
patent: WO 03/16307 (2003-02-01), None
Lee, et al.,J.Het.Chem.,32(1):1-11, 1995.
Mathvink,Bioorganic&Medicinal Chemistry Letters, 9(13): 1869-1874, 1999.
Shuker A J, et al;Tetrahedron Letters; 38(35):6149-6152, 1997.
Weber, et al;Bioorganic&Medicinal Chemistry Letters; 8(9):1101-1106, 1998.
Weber, et al;Bioorganic&Medicinal Chemistry Letters; 8(16):2111-2116, 1998.
Finley Don Richard
Jesudason Cynthia Darshini
Demeter John C.
Eli Lilly and Company
Saeed Kamal A.
Voy Gilbert T.
LandOfFree
2-oxo-benzimidazolyl substituted ethanolamine derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-oxo-benzimidazolyl substituted ethanolamine derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-oxo-benzimidazolyl substituted ethanolamine derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3589907